DVA · News · 20260804N

Reimbursement and Payer Mix

DAVITA INC. · 2026-08-04 · Importance 46 · Surprise 42

Revenue per dialysis treatment declined in the second quarter as patients dropped out of Obamacare plans after pandemic-era subsidies ended. The resulting enrollment and commercial-mix shift pressured treatment economics and reduced the proportion of higher-paying commercial business. DaVita’s dialysis patient base remains primarily served by government payers, increasing sensitivity to reimbursement levels and payer mix.

Key facts

• DaVita said revenue per treatment was lower in the second quarter, blaming declining enrollments for dialysis treatments as patients dropped out of Obamacare plans following the end of pandemic-era subsidies. source